Intestinal Cell News 3.00 January 6, 2017 | |
| |
TOP STORYVGLL4 Targets a TCF4–TEAD4 Complex to Coregulate Wnt and Hippo Signaling in Colorectal Cancer Researchers report that VGLL4, a previously identified YAP antagonist, functions as a regulator of Wnt/β-catenin signaling. The expression of VGLL4 was significantly downregulated in clinical colorectal carcinoma (CRC) specimens, positively associated with patient survival rate, and inversely correlated with the expression of Wnt target genes in CRCs. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)INTESTINAL CANCERS & DISEASESThe authors showed that signal transduction by H2O2 depends on entry into the cell by transit through aquaporin-3 (AQP3), a plasma membrane H2O2-conducting channel. In response to injury, AQP3-depleted colonic epithelial cells showed defective lamellipodia, focal adhesions, and repair after wounding, along with impaired H2O2 responses after exposure to the intestinal pathogen Citrobacter rodentium. [Proc Natl Acad Sci USA] Abstract The objectives of this study were to: synthesize and characterize long-circulating echogenic nanobubble encapsulated low temperature sensitive liposomes and encapsulated non-thermosensitive liposomes, evaluate in vivo drug release following short duration high intensity focused ultrasound (HIFU) treatments administered sequentially over an hour in a large volume of mouse xenograft colon tumor, and determine the impact of the HIFU/nanobubble combination on intratumoral drug distribution. [J Control Release] Abstract Tissue from 19 colorectal mixed adenoneuroendocrine carcinomas and eight colorectal poorly differentiated neuroendocrine neoplasms (neuroendocrine carcinomas) was microdissected and subjected to next-generation sequencing using a colorectal adenocarcinoma-specific panel comprising 196 amplicons covering 32 genes linked to colorectal adenocarcinoma, and poorly differentiated neuroendocrine neoplasm tumorigenesis. [Mod Pathol] Abstract Identification of Genetic Susceptibility Loci for Intestinal Behçet’s Disease Researchers aimed to identify distinctive genetic susceptibility loci/genes associated with intestinal involvement in Behçet’s disease and determine their roles in intestinal inflammation as well as their interactions with genes involved in inflammatory bowel disease. [Sci Rep] Full Article The authors investigated the role of carbonic anhydrase 9 (CA9) via complete genomic knockout (ko) and compared its impact on tumor cell physiology with the essential i regulator Na+/H+ exchanger 1 (NHE1). Initially, they established NHE1-ko LS174 cells with inducible CA9 knockdown. [Oncotarget] Full Article HuR Enhances Early Restitution of the Intestinal Epithelium by Increasing Cdc42 Translation Scientists showed that HuR is essential for early intestinal epithelial restitution by increasing the expression of cell division control protein 42 (Cdc42) at the posttranscriptional level. HuR bound to the Cdc42 mRNA via its 3′-untranslated region and this association specifically enhanced Cdc42 translation without effect on Cdc42 mRNA level. [Mol Cell Biol] Abstract Crosstalk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism Investigators hypothesized that glucuronosyltransferase 1 gene locus (UGT1) A_i2s function into a complex protein network connecting other metabolic pathways with influence on cancer cell metabolism. This is based on a pathway enrichment analysis of proteomic data that identified several high-confidence candidate interaction proteins of UGT1A_i2 proteins in human tissues, namely the rate-limiting enzyme of glycolysis pyruvate kinase, which plays a critical role in cancer cell metabolism and tumor growth. [Mol Pharmacol] Abstract | Full Article Enteric neural stem/progenitor cells (ENSCs) were isolated from the intestines of 25 patients undergoing bowel resection, including 7 children with Hirschsprung disease (HSCR). Neuronal differentiation and proliferation of ENSCs from submucosal and myenteric plexuses from patients with and without HSCR were characterized. [Pediatr Res] Abstract INTESTINAL STEM CELL & ORGANOID RESEARCHScientists assessed angiopoietin-like protein 2 (ANGPTL2) function in intestinal physiology and disease in vivo. Although intestinal development proceeded normally in Angptl2-deficient mice, expression levels of the intestinal stem cell marker gene Lgr5 decreased, which was associated with decreased transcriptional activity of β-catenin in Angptl2-deficient mice. [EMBO J] Full Article Researchers provide novel evidence that microbiota may control intestinal epithelial stem cell proliferation in part through microRNAs (miRNAs). They demonstrated that miRNA profiles differ dramatically across functionally distinct cell types of the mouse jejunal intestinal epithelium and that miRNAs respond to microbiota in a highly cell-type specific manner. [J Biol Chem] Abstract | Full Article | |
| |
REVIEWSCollateral Damage: Insights into Bacterial Mechanisms that Predispose Host Cells to Cancer The authors discuss how bacterial pathogens interact with host cells to contribute to the development of cancer. [Nat Rev Microbiol] Abstract Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn’s Disease Distinguishing intestinal tuberculosis (ITB) from Crohn’s disease (CD) is difficult, although studies have reported clinical, endoscopic, imaging, and laboratory findings that help to differentiate these two diseases. The authors aimed to produce estimates of the predictive power of these findings and construct a comprehensive model to predict the probability of ITB vs. CD. [Am J Gastroenterol] Abstract Visit our reviews page to see a complete list of reviews in the intestinal cell research field. | |
| |
INDUSTRY NEWSEnterome Starts Phase I Clinical Trial with Its Lead Candidate EB8018 to Treat Crohn’s Disease Enterome SA announced the launch of a Phase I clinical study with its lead small molecule drug candidate EB8018, a small molecule designed to block FimH, as a potential new treatment for Crohn’s disease. [Enterome SA] Press Release Rebiotix Inc. announced that the first patient has been treated in a Phase I study of RBX7455 for the prevention of recurrent C. difficile infection. [Rebiotix Inc.] Press Release Takeda and PvP Biologics Announce Development Agreement Around Novel Therapeutic for Celiac Disease Takeda Pharmaceutical Company Limited and PvP Biologics, Inc. announced a global agreement for the development of KumaMax, a novel enzyme designed to break down the immune-reactive parts of gluten in the stomach, thereby avoiding the painful symptoms and damage done in the small intestine from accidental gluten ingestion. [Takeda Pharmaceutical Company Limited] Press Release | |
| |
POLICY NEWSUS Scientists Fear New Restrictions on Fetal-Tissue Research House Republicans conclude that tissue from aborted fetuses is of limited value for research and seek to reduce funding. [Nature News] Editorial Argentina’s Researchers Occupy Science Ministry Hundreds of young researchers occupied Argentina’s science ministry in Buenos Aires last month, angry at budget cuts that they say have denied them permanent jobs at the country’s National Scientific and Technical Research Council. The occupation was the most extreme action yet by Argentinian scientists after months of protests at last year’s budget, the first under President Mauricio Macri. [Nature News] Editorial
| |
EVENTSNEW Keystone Symposium: Tumor Metabolism: Mechanisms and Targets NEW Intestinal Organoid In-Person Training Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Project Scientist – Early Life Microbiota Interaction with the Host (Institute of Food Research) Tenure-Track Position – Various Projects (University Medical Center Utrecht) Assistant Professor – Molecular Therapeutics of Cancer (Dartmouth College) Assistant or Associate Member – Stem Cell/Gene Therapy (Fred Hutchinson Cancer Research Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Intestinal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Intestinal Cell News Volume 3.00 | Jan 6 2017